Influence of dietary fish on eicosanoid metabolism in man.
Two groups of 40 volunteers were given a dietary supplement consisting of 135 g of mackerel or meat (control) paste per day for 6 weeks. Compliance was about 80% in both groups and the daily intake of 20:5(n-3) and 22:6(n-3) from the mackerel supplement was about 1.3 and 2.3 g, respectively. In collagen-activated platelet rich plasma, the potency of blood platelet to produce HHT from arachidonic acid (AA) clearly reduced in the mackerel group, whereas the formation of HHTE from timnodonic acid (TA) increased slightly. Changes in the formation of HHT and HHTE, measured by HPLC, correlated significantly with those of TxB2 and TxB3, respectively, measured by GC/MS. Changes in the formation of the lipoxygenase products HETE (ex AA) and HEPE (ex TA) were qualitatively similar to that seen for the cyclo-oxygenase products, but quantitatively the responses were smaller. Formation of ir TxB2 in clotting blood significantly reduced in the mackerel group. In collagen-activated, citrated whole blood, TxB2 formation tended to be reduced in the mackerel-supplemented volunteers. Mackerel consumption was associated with the formation of considerable amounts of PGI3, as judged from the appearance of 2,3-dinor-delta 17-6-keto-PGF1 alpha in urine. The amount of the major metabolite of PGI2, 2,3-dinor-6-keto-PGF1 alpha was not reduced, or even increased. The daily amount of tetranor prostaglandin metabolites in the urine did not change significantly, which indicates that mackerel supplementation did not alter the formation of prostaglandins E and F.
Honstra
G
G
Department of Human Biology, Limburg University, Maastricht, The Netherlands.
van Houwelingen
A C
AC
Kivits
G A
GA
Fischer
S
S
Uedelhoven
W
W
D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000378:metabolism; D001777:Blood Coagulation / Q000502:physiology; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism; D003094:Collagen / Q000494:pharmacology; D004032:Diet; D015777:Eicosanoids / Q000378:metabolism*; D015118:Eicosapentaenoic Acid / Q000378:metabolism; D011464:Epoprostenol / Q000652:urine; D005227:Fatty Acids / Q000096:biosynthesis; D005396:Fish Products; D006801:Humans; D011453:Prostaglandins / Q000096:biosynthesis; D013929:Thromboxane B2 / Q000031:analogs & derivatives / Q000096:biosynthesis / Q000097:blood; D013931:Thromboxanes / Q000031:analogs & derivatives*
D001095:Arachidonic Acids; D015777:Eicosanoids; D005227:Fatty Acids; D011453:Prostaglandins; D013931:Thromboxanes; D016718:Arachidonic Acid; D013929:Thromboxane B2; D003094:Collagen; D015118:Eicosapentaenoic Acid; D011464:Epoprostenol; C039158:thromboxane B3